SlideShare uma empresa Scribd logo
1 de 54
Baixar para ler offline
Parathyroid gland function and
dysfunction in dialysis patients
Amr El-Husseini Mohamed
MD, FACP, FASN
Professor of Medicine
Medical Director
University of Kentucky
July 25th 2018
Disclosure
• Nothing to disclose
• Salaried UK employee
How many organs in our body
do we have 4 copies of ?
Parathyroid Gland
Amount of daily PTH secretion
9,43kDa (PTH molecaular weight) = 1.57 exp-08 pg/molc
50 pg/mL/ 1.57 exp-08 pg/molecules = 3,184 exp 6 molecules
3184 millions of PTH molecules in 50pg/mL.
3184.000.000 X 3500 X 6 X 24
1.337.280.000.000.000 Molecules
Why does PTH go up
in our patient?
What is the order of sequences
• Hyperphosphatemia
• Hypocalcemia
• Decrease Calcitriol level
• Increase PTH level
• Increase FGF-23 level
Calcitriol Decline and iPTH Elevation
as CKD Progresses
N = 150.
iPTH = intact PTH.
eGFR (mL/min/1.73 m2)
152535455565758595105
100
200
300
400
0
10
20
30
40
50
iPTH(pg/mL)
Calcitriol
1,25(OH)2D3(pg/mL)
Stage 3
7.4 million
Stage 2
5.7 million
Stage 4
300,000
CKD Stage 1
5.6 million
25
65
Low-Normal
Calcitriol
High-Normal
PTH
© 2005 The Johns Hopkins University School of Medicine.
Proceedings of the National Academy of Sciences. 1963; 49: 613-617
Berson et al., discovered single polyclonal
antibody against epitopes in the carboxy-
terminal end of the PTH molecule.
This was an innovation and opened the
door for a revolution in PTH
measurements.
Kevin Martin DiaSorin 2015
900
800
700
600
500
400
300
200
100
Total I-PTH = 1000 pg/ml
El-Husseini et al. (Semin Nephrol 2018, in press)
El-Husseini et al. (Semin Nephrol 2018, in press)
Why do we need to
treat SPTH ?
CKD-MBD
Population Attributable Risk of All
Cause Mortality in CKD 5D
• 17.5% Mineral metabolism abnormalities
(Phosphorus > 5.0 mg/dl, Calcium >
10 mg/dl, intact PTH > 600 pg/ml)
• 11.3% Anemia (hgb < 11 g/dl)
• 5.1% Inefficient Dialysis (URR < 65%)
We should be able to significantly improve
mortality of CKD patients by improving
control of CKD-MBD.
Block et al JASN 2004
Vascular Calcification and CKD
Patient Without CKD
Intimal Calcification
Secondary to
Atherosclerosis
Medial Calcification
Secondary to CKD
Patients With CKD
Rib
Vertebra
EBCT Indicating Coronary
Calcification
Raggi P. Clin Nephrol. 2000;54:325-333.
EBCT=electron beam computed tomography.
Renal osteodystrophy pattern based on bone biopsy.
K/DOQI-recommended iPTH levels do not prevent LTB disease in HD patients
Barreto et al., Kidney International, 2008
82%
64%
37%
60%
37%
62%
Renal osteodystrophy: Analysis of 630
bone biopsies
Malluche et al., JBMR 2011
40%
36%
62%
20%
PTH level was not a significant predictor of BT in Blacks.
58%
24%
18%
Tentori et al., AJKD 2015
Sprague et al., AJKD 2016
Felix Mandl in Vienna, performed the first documented
parathyroidectomy in 1925 on a 34-year-old man with
compensatory parathyroid hyperplasia in OFC
Parathyroidectomy improves laboratory
parameters in resistant hyperparathyroidism
with the assumption that clinical outcomes
will also improve.
However, no RCT to demonstrate the
benefits of parathyroidectomy.
Floege et al., NDT 2011
iPTH and mortality
What is a successful
parathyroidectomy ?
A decrease of iPTH levels > 80 %
A decrease of iPTH levels > 90 %
No need for another surgery
PTH levels were not significantly lower in the TPTX group until 36 months
MeanPTHatdischarge
54ng/L
MeanPTHat3years
24versus75ng/L
Schlosser et al., Ann Surg. 2016
52
48
PTH was < 75 ng/L in >90 %
Successful PTX was defined if iPTH was <300 pg/mL
Zhang et al., Sci Rep. 2016
90%
10%
501 patients
iPTH levels after PTx
0
100
200
300
400
500
600
700
800
900
1000
Category 1
Preop iPTH
Postop iPTH
3 months iPTH147 pg/mL
16–498 47 pg/mL
1–515
Roshan et al., Clin Otolaryngol 2006
932 pg/mL
58–1808
Preop iPTH Postop iPTH 3 Months iPTH
El-Husseini et al. (Nephron Clinical Practice, 2018)
31 % of the patients were readmitted within 90 days
mostly because of hypocalcemia (74%).
> 80% of patients had iPTH < 150 pg/mL overtime
N = 87
Do we need Bone biopsy prior to PTX ?
Prior to PTX, aluminum toxicity and adynamic bone disease should be
excluded particularly if PTH is not severely elevated.
Parathyroidectomy can worsen symptoms of aluminum and nonaluminum-
related adynamic bone disease, especially if hypoparathyroidism is induced.
El-Husseini and Sawaya, Semin Dial. 2014
May 2017
PLoS One. 2017 Apr 6;12 (4): e0174811
Tentori et al., AJKD 2015
89% had ≥ 30% reduction in PTH.
A mean 53.6% decrease in PTH level.
Bushinsky et al., Am J Nephrol. 2015
Etelcalcitide
Benefits
Cure
Definitive
Less expensive
Avoid long term
meds SE
Minimally invasive
Risks
Hypoparathyroid
No return
Trash vital organ
Needs long term
meds
Complications
No RCT
Need long-term follow up after PTX
Assay and target PTH levels in ESRD
Be ready to treat hypoparathyroidism
Your enemy today can be your friend tomorrow. Hopefully, we are not killing our
tomorrow's friend.
Prof.Amr El Husseini Mohamed

Mais conteúdo relacionado

Mais procurados

Aki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyanAki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyanCHAKEN MANIYAN
 
FINAL CURO 2016 Szymonik
FINAL CURO 2016 SzymonikFINAL CURO 2016 Szymonik
FINAL CURO 2016 SzymonikJoanna Szymonik
 
B cell malignancies and the Kidney
B cell malignancies and the KidneyB cell malignancies and the Kidney
B cell malignancies and the Kidneykdj200
 
Medical Therapy of Castration Resistance Prostate Cancer
Medical Therapy of Castration Resistance Prostate CancerMedical Therapy of Castration Resistance Prostate Cancer
Medical Therapy of Castration Resistance Prostate CancerEuropa Uomo EPAD
 
Hemostatic effect of tranexamic acid in elective nasal
Hemostatic effect of tranexamic acid in elective nasalHemostatic effect of tranexamic acid in elective nasal
Hemostatic effect of tranexamic acid in elective nasalAngus Shao
 
Cardiac Inflammation and Repair Following Myocardial Infarction
Cardiac Inflammation and Repair Following Myocardial InfarctionCardiac Inflammation and Repair Following Myocardial Infarction
Cardiac Inflammation and Repair Following Myocardial InfarctionInsideScientific
 
Androgen Deprivation Therapy for Prostate Cancer
Androgen Deprivation Therapy for Prostate CancerAndrogen Deprivation Therapy for Prostate Cancer
Androgen Deprivation Therapy for Prostate CancerAlexander Small
 
Fda Iri Dgf Workshop 09 Sep2011 W Irish
Fda Iri Dgf Workshop 09 Sep2011 W IrishFda Iri Dgf Workshop 09 Sep2011 W Irish
Fda Iri Dgf Workshop 09 Sep2011 W Irishbirish
 
Hormone Resistant Prostate Cancer
Hormone Resistant Prostate CancerHormone Resistant Prostate Cancer
Hormone Resistant Prostate CancerSantam Chakraborty
 
Renal hyperparathyrodism
Renal hyperparathyrodismRenal hyperparathyrodism
Renal hyperparathyrodismFarragBahbah
 
Jason G. Attaman, DO, FAAPMR Presents: Image Guided Platelet Rich Plasma (PRP...
Jason G. Attaman, DO, FAAPMR Presents: Image Guided Platelet Rich Plasma (PRP...Jason G. Attaman, DO, FAAPMR Presents: Image Guided Platelet Rich Plasma (PRP...
Jason G. Attaman, DO, FAAPMR Presents: Image Guided Platelet Rich Plasma (PRP...Jason Attaman
 
Journal club SMART trial NEJM
Journal club  SMART trial NEJM Journal club  SMART trial NEJM
Journal club SMART trial NEJM CHAKEN MANIYAN
 
ESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. GawadESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. GawadNephroTube - Dr.Gawad
 
Uses of prp in different gynecological disorders
Uses of prp in different gynecological disordersUses of prp in different gynecological disorders
Uses of prp in different gynecological disordersAyman Shehata
 
Uremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. GawadUremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. GawadNephroTube - Dr.Gawad
 
Thalassemia Chelation Update: Prof Raymond Wong
Thalassemia Chelation Update: Prof Raymond WongThalassemia Chelation Update: Prof Raymond Wong
Thalassemia Chelation Update: Prof Raymond Wongspa718
 

Mais procurados (19)

Aki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyanAki biomarker 2016 chaken maniyan
Aki biomarker 2016 chaken maniyan
 
FINAL CURO 2016 Szymonik
FINAL CURO 2016 SzymonikFINAL CURO 2016 Szymonik
FINAL CURO 2016 Szymonik
 
B cell malignancies and the Kidney
B cell malignancies and the KidneyB cell malignancies and the Kidney
B cell malignancies and the Kidney
 
Erythropoetin - From Bench to Bedside
Erythropoetin - From Bench to BedsideErythropoetin - From Bench to Bedside
Erythropoetin - From Bench to Bedside
 
Medical Therapy of Castration Resistance Prostate Cancer
Medical Therapy of Castration Resistance Prostate CancerMedical Therapy of Castration Resistance Prostate Cancer
Medical Therapy of Castration Resistance Prostate Cancer
 
Hemostatic effect of tranexamic acid in elective nasal
Hemostatic effect of tranexamic acid in elective nasalHemostatic effect of tranexamic acid in elective nasal
Hemostatic effect of tranexamic acid in elective nasal
 
Cardiac Inflammation and Repair Following Myocardial Infarction
Cardiac Inflammation and Repair Following Myocardial InfarctionCardiac Inflammation and Repair Following Myocardial Infarction
Cardiac Inflammation and Repair Following Myocardial Infarction
 
Androgen Deprivation Therapy for Prostate Cancer
Androgen Deprivation Therapy for Prostate CancerAndrogen Deprivation Therapy for Prostate Cancer
Androgen Deprivation Therapy for Prostate Cancer
 
Fda Iri Dgf Workshop 09 Sep2011 W Irish
Fda Iri Dgf Workshop 09 Sep2011 W IrishFda Iri Dgf Workshop 09 Sep2011 W Irish
Fda Iri Dgf Workshop 09 Sep2011 W Irish
 
Hormone Resistant Prostate Cancer
Hormone Resistant Prostate CancerHormone Resistant Prostate Cancer
Hormone Resistant Prostate Cancer
 
Renal hyperparathyrodism
Renal hyperparathyrodismRenal hyperparathyrodism
Renal hyperparathyrodism
 
Jason G. Attaman, DO, FAAPMR Presents: Image Guided Platelet Rich Plasma (PRP...
Jason G. Attaman, DO, FAAPMR Presents: Image Guided Platelet Rich Plasma (PRP...Jason G. Attaman, DO, FAAPMR Presents: Image Guided Platelet Rich Plasma (PRP...
Jason G. Attaman, DO, FAAPMR Presents: Image Guided Platelet Rich Plasma (PRP...
 
Justin Hall, Urolift
Justin Hall, UroliftJustin Hall, Urolift
Justin Hall, Urolift
 
kewal krishan
kewal krishankewal krishan
kewal krishan
 
Journal club SMART trial NEJM
Journal club  SMART trial NEJM Journal club  SMART trial NEJM
Journal club SMART trial NEJM
 
ESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. GawadESAs Therapy: Friend or Foe? - Dr. Gawad
ESAs Therapy: Friend or Foe? - Dr. Gawad
 
Uses of prp in different gynecological disorders
Uses of prp in different gynecological disordersUses of prp in different gynecological disorders
Uses of prp in different gynecological disorders
 
Uremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. GawadUremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. Gawad
 
Thalassemia Chelation Update: Prof Raymond Wong
Thalassemia Chelation Update: Prof Raymond WongThalassemia Chelation Update: Prof Raymond Wong
Thalassemia Chelation Update: Prof Raymond Wong
 

Semelhante a Prof.Amr El Husseini Mohamed

Secondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney TransplantationSecondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney TransplantationChristos Argyropoulos
 
Hyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantationHyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantationChristos Argyropoulos
 
Use of iohexol clearance in dogs as a diagnostic test
Use of iohexol clearance in dogs as a diagnostic testUse of iohexol clearance in dogs as a diagnostic test
Use of iohexol clearance in dogs as a diagnostic testDr.hema hassan
 
New Approaches To The Treatment Of Hyperphosphataemia (CRF)
New Approaches To The Treatment Of Hyperphosphataemia (CRF)New Approaches To The Treatment Of Hyperphosphataemia (CRF)
New Approaches To The Treatment Of Hyperphosphataemia (CRF)Andre Garcia
 
Renal replacement therapy in intensive care
Renal replacement therapy in intensive careRenal replacement therapy in intensive care
Renal replacement therapy in intensive careAndrew Ferguson
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failureguest2379201
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal FailureDang Thanh Tuan
 
AKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptxAKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptxDrHarsh Saxena
 
Management of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptxManagement of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptxChristos Argyropoulos
 
Pentoxyfilline in Diabetic Renal Disease and Renal Transplantation
Pentoxyfilline in Diabetic Renal Disease and Renal TransplantationPentoxyfilline in Diabetic Renal Disease and Renal Transplantation
Pentoxyfilline in Diabetic Renal Disease and Renal TransplantationChristos Argyropoulos
 
PTH - Chronic Renal Failure
PTH - Chronic Renal FailurePTH - Chronic Renal Failure
PTH - Chronic Renal FailureAndre Garcia
 
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...Peter McCullough, Early Identification and Assessment of Acute and Chronic K...
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...Cleveland HeartLab, Inc.
 
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. GawadCKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. GawadNephroTube - Dr.Gawad
 
Post parathyroidectomy hypocalcemia dng 2019prof.osama elshahata
Post parathyroidectomy hypocalcemia  dng 2019prof.osama elshahataPost parathyroidectomy hypocalcemia  dng 2019prof.osama elshahata
Post parathyroidectomy hypocalcemia dng 2019prof.osama elshahataFAARRAG
 
Pathophysiological mechanisms and consequences of gut edema (Annika Reintam W...
Pathophysiological mechanisms and consequences of gut edema (Annika Reintam W...Pathophysiological mechanisms and consequences of gut edema (Annika Reintam W...
Pathophysiological mechanisms and consequences of gut edema (Annika Reintam W...WSACS
 
Radiation Therapy: Nutritional Strategies to Improve Outcomes
Radiation Therapy: Nutritional Strategies to Improve OutcomesRadiation Therapy: Nutritional Strategies to Improve Outcomes
Radiation Therapy: Nutritional Strategies to Improve OutcomesJeanne M Wallace PhD
 
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...Hussain Karimi
 

Semelhante a Prof.Amr El Husseini Mohamed (20)

Secondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney TransplantationSecondary Hyperparathyroidism in Kidney Transplantation
Secondary Hyperparathyroidism in Kidney Transplantation
 
Hyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantationHyperparathyroidism after kidney transplantation
Hyperparathyroidism after kidney transplantation
 
Use of iohexol clearance in dogs as a diagnostic test
Use of iohexol clearance in dogs as a diagnostic testUse of iohexol clearance in dogs as a diagnostic test
Use of iohexol clearance in dogs as a diagnostic test
 
New Approaches To The Treatment Of Hyperphosphataemia (CRF)
New Approaches To The Treatment Of Hyperphosphataemia (CRF)New Approaches To The Treatment Of Hyperphosphataemia (CRF)
New Approaches To The Treatment Of Hyperphosphataemia (CRF)
 
Renal replacement therapy in intensive care
Renal replacement therapy in intensive careRenal replacement therapy in intensive care
Renal replacement therapy in intensive care
 
Bellomo assisi
Bellomo assisiBellomo assisi
Bellomo assisi
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
 
AKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptxAKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptx
 
Management of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptxManagement of SHPT in dialysis and beyond.pptx
Management of SHPT in dialysis and beyond.pptx
 
Pentoxyfilline in Diabetic Renal Disease and Renal Transplantation
Pentoxyfilline in Diabetic Renal Disease and Renal TransplantationPentoxyfilline in Diabetic Renal Disease and Renal Transplantation
Pentoxyfilline in Diabetic Renal Disease and Renal Transplantation
 
PTH - Chronic Renal Failure
PTH - Chronic Renal FailurePTH - Chronic Renal Failure
PTH - Chronic Renal Failure
 
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...Peter McCullough, Early Identification and Assessment of Acute and Chronic K...
Peter McCullough, Early Identification and Assessment of Acute and Chronic K...
 
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. GawadCKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
 
Post parathyroidectomy hypocalcemia dng 2019prof.osama elshahata
Post parathyroidectomy hypocalcemia  dng 2019prof.osama elshahataPost parathyroidectomy hypocalcemia  dng 2019prof.osama elshahata
Post parathyroidectomy hypocalcemia dng 2019prof.osama elshahata
 
RRT
RRTRRT
RRT
 
Pathophysiological mechanisms and consequences of gut edema (Annika Reintam W...
Pathophysiological mechanisms and consequences of gut edema (Annika Reintam W...Pathophysiological mechanisms and consequences of gut edema (Annika Reintam W...
Pathophysiological mechanisms and consequences of gut edema (Annika Reintam W...
 
Gouty Athritis , Cause of painful joints ,pseudo gout
Gouty Athritis , Cause of painful joints ,pseudo gout Gouty Athritis , Cause of painful joints ,pseudo gout
Gouty Athritis , Cause of painful joints ,pseudo gout
 
Radiation Therapy: Nutritional Strategies to Improve Outcomes
Radiation Therapy: Nutritional Strategies to Improve OutcomesRadiation Therapy: Nutritional Strategies to Improve Outcomes
Radiation Therapy: Nutritional Strategies to Improve Outcomes
 
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
IDENTIFYING PARATHYROID HORMONE DISORDERS AND ITS PHENOTYPES THROUGH A BONE H...
 

Mais de FarragBahbah

Modified therapeutic plasma-exchange
Modified therapeutic plasma-exchangeModified therapeutic plasma-exchange
Modified therapeutic plasma-exchangeFarragBahbah
 
Hussein drug therapy in aki 3 osama alshahat 2 pptx
Hussein drug therapy in aki 3 osama alshahat 2 pptxHussein drug therapy in aki 3 osama alshahat 2 pptx
Hussein drug therapy in aki 3 osama alshahat 2 pptxFarragBahbah
 
Pres ln master class 21 oct 2019
Pres ln master class 21 oct 2019 Pres ln master class 21 oct 2019
Pres ln master class 21 oct 2019 FarragBahbah
 
Fluid management in pd patient
Fluid management in pd patientFluid management in pd patient
Fluid management in pd patientFarragBahbah
 
Membranous nephropathy 22 october 2019, prof. hussein sheashaa
Membranous nephropathy 22 october 2019, prof. hussein sheashaaMembranous nephropathy 22 october 2019, prof. hussein sheashaa
Membranous nephropathy 22 october 2019, prof. hussein sheashaaFarragBahbah
 
Toxicology emergency dr.farrag megahed
Toxicology  emergency dr.farrag megahedToxicology  emergency dr.farrag megahed
Toxicology emergency dr.farrag megahedFarragBahbah
 
Interstial nephr mohamed abdallah
Interstial nephr mohamed abdallahInterstial nephr mohamed abdallah
Interstial nephr mohamed abdallahFarragBahbah
 
Fasting ramadan nephrology prospective prof. osama el shahate
Fasting ramadan nephrology prospective prof. osama el shahateFasting ramadan nephrology prospective prof. osama el shahate
Fasting ramadan nephrology prospective prof. osama el shahateFarragBahbah
 
Ramadan fasting &amp; kidney disease may 2019
Ramadan fasting &amp; kidney disease may 2019Ramadan fasting &amp; kidney disease may 2019
Ramadan fasting &amp; kidney disease may 2019FarragBahbah
 
Diet managment in ramadan dr doaa hamed
Diet managment in ramadan  dr doaa hamedDiet managment in ramadan  dr doaa hamed
Diet managment in ramadan dr doaa hamedFarragBahbah
 
Vascular access 2019
Vascular access 2019Vascular access 2019
Vascular access 2019FarragBahbah
 
الرعاية-الغذائية-لمرضي-الكلي-كوبري-القبة-يناير-2019
الرعاية-الغذائية-لمرضي-الكلي-كوبري-القبة-يناير-2019الرعاية-الغذائية-لمرضي-الكلي-كوبري-القبة-يناير-2019
الرعاية-الغذائية-لمرضي-الكلي-كوبري-القبة-يناير-2019FarragBahbah
 
الدليل الإرشادي لمرضي القصور الكلوي د.دعاء حامد .د.اسامه الشحات
الدليل الإرشادي لمرضي القصور الكلوي د.دعاء حامد .د.اسامه الشحاتالدليل الإرشادي لمرضي القصور الكلوي د.دعاء حامد .د.اسامه الشحات
الدليل الإرشادي لمرضي القصور الكلوي د.دعاء حامد .د.اسامه الشحاتFarragBahbah
 
Parathyroidectomy alshimaa
Parathyroidectomy  alshimaaParathyroidectomy  alshimaa
Parathyroidectomy alshimaaFarragBahbah
 

Mais de FarragBahbah (20)

Pd aki 2019
Pd aki 2019Pd aki 2019
Pd aki 2019
 
Modified therapeutic plasma-exchange
Modified therapeutic plasma-exchangeModified therapeutic plasma-exchange
Modified therapeutic plasma-exchange
 
Hussein drug therapy in aki 3 osama alshahat 2 pptx
Hussein drug therapy in aki 3 osama alshahat 2 pptxHussein drug therapy in aki 3 osama alshahat 2 pptx
Hussein drug therapy in aki 3 osama alshahat 2 pptx
 
Pres ln master class 21 oct 2019
Pres ln master class 21 oct 2019 Pres ln master class 21 oct 2019
Pres ln master class 21 oct 2019
 
Fluid management in pd patient
Fluid management in pd patientFluid management in pd patient
Fluid management in pd patient
 
Membranous nephropathy 22 october 2019, prof. hussein sheashaa
Membranous nephropathy 22 october 2019, prof. hussein sheashaaMembranous nephropathy 22 october 2019, prof. hussein sheashaa
Membranous nephropathy 22 october 2019, prof. hussein sheashaa
 
Dialysis in aki
Dialysis in akiDialysis in aki
Dialysis in aki
 
Dkd master class
Dkd master class Dkd master class
Dkd master class
 
Gn master class
Gn master classGn master class
Gn master class
 
Ibrahim
IbrahimIbrahim
Ibrahim
 
Aya elsaeid 1
Aya elsaeid 1Aya elsaeid 1
Aya elsaeid 1
 
Toxicology emergency dr.farrag megahed
Toxicology  emergency dr.farrag megahedToxicology  emergency dr.farrag megahed
Toxicology emergency dr.farrag megahed
 
Interstial nephr mohamed abdallah
Interstial nephr mohamed abdallahInterstial nephr mohamed abdallah
Interstial nephr mohamed abdallah
 
Fasting ramadan nephrology prospective prof. osama el shahate
Fasting ramadan nephrology prospective prof. osama el shahateFasting ramadan nephrology prospective prof. osama el shahate
Fasting ramadan nephrology prospective prof. osama el shahate
 
Ramadan fasting &amp; kidney disease may 2019
Ramadan fasting &amp; kidney disease may 2019Ramadan fasting &amp; kidney disease may 2019
Ramadan fasting &amp; kidney disease may 2019
 
Diet managment in ramadan dr doaa hamed
Diet managment in ramadan  dr doaa hamedDiet managment in ramadan  dr doaa hamed
Diet managment in ramadan dr doaa hamed
 
Vascular access 2019
Vascular access 2019Vascular access 2019
Vascular access 2019
 
الرعاية-الغذائية-لمرضي-الكلي-كوبري-القبة-يناير-2019
الرعاية-الغذائية-لمرضي-الكلي-كوبري-القبة-يناير-2019الرعاية-الغذائية-لمرضي-الكلي-كوبري-القبة-يناير-2019
الرعاية-الغذائية-لمرضي-الكلي-كوبري-القبة-يناير-2019
 
الدليل الإرشادي لمرضي القصور الكلوي د.دعاء حامد .د.اسامه الشحات
الدليل الإرشادي لمرضي القصور الكلوي د.دعاء حامد .د.اسامه الشحاتالدليل الإرشادي لمرضي القصور الكلوي د.دعاء حامد .د.اسامه الشحات
الدليل الإرشادي لمرضي القصور الكلوي د.دعاء حامد .د.اسامه الشحات
 
Parathyroidectomy alshimaa
Parathyroidectomy  alshimaaParathyroidectomy  alshimaa
Parathyroidectomy alshimaa
 

Último

Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 

Último (20)

Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 

Prof.Amr El Husseini Mohamed

  • 1. Parathyroid gland function and dysfunction in dialysis patients Amr El-Husseini Mohamed MD, FACP, FASN Professor of Medicine Medical Director University of Kentucky July 25th 2018
  • 2. Disclosure • Nothing to disclose • Salaried UK employee
  • 3. How many organs in our body do we have 4 copies of ?
  • 5.
  • 6. Amount of daily PTH secretion 9,43kDa (PTH molecaular weight) = 1.57 exp-08 pg/molc 50 pg/mL/ 1.57 exp-08 pg/molecules = 3,184 exp 6 molecules 3184 millions of PTH molecules in 50pg/mL. 3184.000.000 X 3500 X 6 X 24 1.337.280.000.000.000 Molecules
  • 7. Why does PTH go up in our patient?
  • 8.
  • 9.
  • 10. What is the order of sequences • Hyperphosphatemia • Hypocalcemia • Decrease Calcitriol level • Increase PTH level • Increase FGF-23 level
  • 11.
  • 12.
  • 13. Calcitriol Decline and iPTH Elevation as CKD Progresses N = 150. iPTH = intact PTH. eGFR (mL/min/1.73 m2) 152535455565758595105 100 200 300 400 0 10 20 30 40 50 iPTH(pg/mL) Calcitriol 1,25(OH)2D3(pg/mL) Stage 3 7.4 million Stage 2 5.7 million Stage 4 300,000 CKD Stage 1 5.6 million 25 65 Low-Normal Calcitriol High-Normal PTH © 2005 The Johns Hopkins University School of Medicine.
  • 14.
  • 15. Proceedings of the National Academy of Sciences. 1963; 49: 613-617 Berson et al., discovered single polyclonal antibody against epitopes in the carboxy- terminal end of the PTH molecule. This was an innovation and opened the door for a revolution in PTH measurements.
  • 16.
  • 17.
  • 18. Kevin Martin DiaSorin 2015 900 800 700 600 500 400 300 200 100 Total I-PTH = 1000 pg/ml
  • 19.
  • 20. El-Husseini et al. (Semin Nephrol 2018, in press)
  • 21. El-Husseini et al. (Semin Nephrol 2018, in press)
  • 22.
  • 23. Why do we need to treat SPTH ?
  • 24.
  • 25.
  • 27. Population Attributable Risk of All Cause Mortality in CKD 5D • 17.5% Mineral metabolism abnormalities (Phosphorus > 5.0 mg/dl, Calcium > 10 mg/dl, intact PTH > 600 pg/ml) • 11.3% Anemia (hgb < 11 g/dl) • 5.1% Inefficient Dialysis (URR < 65%) We should be able to significantly improve mortality of CKD patients by improving control of CKD-MBD. Block et al JASN 2004
  • 28. Vascular Calcification and CKD Patient Without CKD Intimal Calcification Secondary to Atherosclerosis Medial Calcification Secondary to CKD Patients With CKD Rib Vertebra EBCT Indicating Coronary Calcification Raggi P. Clin Nephrol. 2000;54:325-333. EBCT=electron beam computed tomography.
  • 29.
  • 30.
  • 31. Renal osteodystrophy pattern based on bone biopsy. K/DOQI-recommended iPTH levels do not prevent LTB disease in HD patients Barreto et al., Kidney International, 2008 82% 64% 37% 60% 37% 62%
  • 32. Renal osteodystrophy: Analysis of 630 bone biopsies Malluche et al., JBMR 2011 40% 36% 62% 20% PTH level was not a significant predictor of BT in Blacks. 58% 24% 18%
  • 33.
  • 34. Tentori et al., AJKD 2015
  • 35. Sprague et al., AJKD 2016
  • 36. Felix Mandl in Vienna, performed the first documented parathyroidectomy in 1925 on a 34-year-old man with compensatory parathyroid hyperplasia in OFC
  • 37. Parathyroidectomy improves laboratory parameters in resistant hyperparathyroidism with the assumption that clinical outcomes will also improve. However, no RCT to demonstrate the benefits of parathyroidectomy.
  • 38. Floege et al., NDT 2011 iPTH and mortality
  • 39. What is a successful parathyroidectomy ? A decrease of iPTH levels > 80 % A decrease of iPTH levels > 90 % No need for another surgery
  • 40. PTH levels were not significantly lower in the TPTX group until 36 months MeanPTHatdischarge 54ng/L MeanPTHat3years 24versus75ng/L Schlosser et al., Ann Surg. 2016 52 48 PTH was < 75 ng/L in >90 %
  • 41. Successful PTX was defined if iPTH was <300 pg/mL Zhang et al., Sci Rep. 2016 90% 10% 501 patients
  • 42. iPTH levels after PTx 0 100 200 300 400 500 600 700 800 900 1000 Category 1 Preop iPTH Postop iPTH 3 months iPTH147 pg/mL 16–498 47 pg/mL 1–515 Roshan et al., Clin Otolaryngol 2006 932 pg/mL 58–1808 Preop iPTH Postop iPTH 3 Months iPTH
  • 43. El-Husseini et al. (Nephron Clinical Practice, 2018) 31 % of the patients were readmitted within 90 days mostly because of hypocalcemia (74%). > 80% of patients had iPTH < 150 pg/mL overtime N = 87
  • 44. Do we need Bone biopsy prior to PTX ? Prior to PTX, aluminum toxicity and adynamic bone disease should be excluded particularly if PTH is not severely elevated. Parathyroidectomy can worsen symptoms of aluminum and nonaluminum- related adynamic bone disease, especially if hypoparathyroidism is induced. El-Husseini and Sawaya, Semin Dial. 2014
  • 45.
  • 46.
  • 48. PLoS One. 2017 Apr 6;12 (4): e0174811
  • 49. Tentori et al., AJKD 2015
  • 50. 89% had ≥ 30% reduction in PTH. A mean 53.6% decrease in PTH level. Bushinsky et al., Am J Nephrol. 2015 Etelcalcitide
  • 51. Benefits Cure Definitive Less expensive Avoid long term meds SE Minimally invasive Risks Hypoparathyroid No return Trash vital organ Needs long term meds Complications
  • 52. No RCT Need long-term follow up after PTX Assay and target PTH levels in ESRD Be ready to treat hypoparathyroidism
  • 53. Your enemy today can be your friend tomorrow. Hopefully, we are not killing our tomorrow's friend.